Learn more Got it! TECHNOLOGY AR-V7 BIOPHARMA SOLUTIONS PUBLICATIONS & RESOURCES PUBLICATIONS SCIENTIFIC POSTERS PACKAGE INSERTS LIBRARY PODCASTS & WEBINARS NEWS & EVENTS PRESS RELEASES NEWS EVENTS COMPANY CONTACT SIGN UP LATEST NEWS EPIC SCIENCES COMPREHENSIVE CANCER PROFILING PLATFORM SHOWS COMPELLING VALUE OF CELL ANALYSIS IN DATA PRESENTED AT ESMO CONGRESS 2021 Read More THE CELL HOLDS THE ANSWERS, AND OUR TESTS UNLOCK THOSE ANSWERS TO EXTEND LIVES. TECHNOLOGY Epic Sciences' groundbreaking, unbiased approach using Comprehensive Cancer Profiling liquid biopsy platform, sees those rare cells that others miss. By peering more deeply into the single cell, we can perceive both genotype and phenotypes together, and delivering tests that are personalized, predictive and proven. We give cancer patients and their physicians the clear, accurate insights they need to choose the best course of therapy. LEARN MORE AR-V7 TEST The AR-V7 test is the first and only CTC-based liquid-biopsy test that is Medicare reimbursed and clinically-validated for men with metastatic castration-resistant prostate cancer (mCRPC). Requiring only a simple, non-invasive blood draw, this groundbreaking test empowers patients, with their doctors, the confidence to choose the most effective precision therapies. LEARN MORE BIOPHARMA SOLUTIONS For pharmaceutical and clinical investigation partners, our program delivers a bias-free approach for cancer research, to develop clinical solutions that enhance drug development and provide valuable insights into the dynamics of cancer growth and evolution. 0 CANCER TYPES 0 ACADEMIC PARTNERS 0 PHARMACEUTICAL PARTNERS >0 PUBLICATIONS >0 CLINICAL TRIALS >0 SINGLE CTC GENOMES SEQUENCED >0 PATIENT SAMPLES CONTRACTED VIEW OUR SOLUTIONS WHAT SOURCES ARE SAYING READ THE ARTICLES LATEST TWEETS EPIC SCIENCES IS CREATING A BREAKTHROUGH NEW CATEGORY OF CANCER DIAGNOSTICS. In a blood sample of a patient with metastatic cancer there are roughly 50 million cells and only about 5 are cancer cells with the potential to form tumors elsewhere in the body. Other diagnostics can’t see them, but we can. READ OUR PUBLICATIONS MENU AR-V7 Test Biopharma Solutions Publications News Center Company Careers Contact Us Privacy Policy 9381 Judicial Drive, Suite 200 San Diego, CA 92121 858-356-6610 General Information:info@epicsciences.com Investor Relations:ir@epicsciences.com Media Inquiries:media@epicsciences.com HR Inquiries:careers@epicsciences.com ©2020 Epic Sciences v.B – LBL 00074 – 2020 ‘No Cell Left Behind’ and ‘The Power of Clarity’ are registered trademarks of Epic Sciences in the United States. Epic Sciences is licensed under the Clinical Laboratory Improvement Amendment of 1988 (“CLIA”) and is authorized to provide diagnostic laboratory services in the following states: California New York Florida Maryland Pennsylvania Rhode Island